| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |